(and dosage form):
Each 5 mL of syrup contains:
Carbocisteine 250 mg
Methyl hydroxybenzoate 0,17% m/v
A 10.2.2 Medicines acting on respiratory system: Other.
FLEMGO reduces the viscosity of non-infected secretions from mucous cells in the respiratory tract.
Adjunctive therapy in respiratory tract disorders characterized by excessive viscous mucous in the absence of infection.
Hypersensitivity to any of the ingredients. Active peptic ulcer.
DOSAGE AND DIRECTIONS FOR USE:
Adults: Two to three medicine measurefuls (10 mL to 15 mL), three times daily.
Children 5 - 12 years: One medicine measureful (5 mL) three times daily.
Children 2 - 5 years: Half a medicine measureful (2,5 mL) two to four times daily according to age.
SIDE-EFFECTS AND SPECIAL PRECAUTIONS:
Nausea, diarrhoea and headache may occur. FLEMGO should be administered with caution to patients with a history of gastric or duodenal ulcer. The safety of FLEMGO in pregnancy has not been established.
KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:
Refer to "Side-effects and special precautions". Treatment is supportive and symptomatic.
FLEMGO is a clear red syrupy liquid with a pleasant cherry flavour.
200 mL and 2,5 litre plastic bottles.
Store in a cool place, below 25°C. Protect from light.
KEEP OUT OF REACH OF CHILDREN.
NAME AND BUSINESS ADDRESS OF THE APPLICANT:
Geo Schwulst Laboratories Limited
17 Faraday St.,
Village Main, Jhb
DATE OF PUBLICATION OF THIS PACKAGE INSERT:
SAEPI HOME PAGE
TRADE NAME INDEX
GENERIC NAME INDEX
Information presented by Malahyde Information Systems © Copyright 1996,1997,1998